Scientific Advisory Committee

The Weston Brain Institute has a diverse group of leading scientific experts who adjudicate all grant applications and provide guidance with respect to program development. This guidance is sought to comply with the Foundation’s mission to support proactive, narrowly focused, impactful research.

The Scientific Advisory Committee provides guidance to the Weston Brain Institute regarding overall strategy, program development and program design. Advisors also participate in the review committees for the various granting programs.

  • Dr. Barbara Bendlin

    Dr. Barbara Bendlin is an Associate Professor of Medicine at the University of Wisconsin-Madison, and an investigator at the Wisconsin Alzheimer’s Disease Research Center (ADRC). Dr. Bendlin leads a large federally funded translational research program centered on identifying the earliest brain changes that occur in the course of Alzheimer’s disease, determining factors that increase...

  • Dr. Claire Henchcliffe

    Claire Henchcliffe, M.D., D.Phil. is the Vice Chair for Clinical Research in Neurology and the Director of the Parkinson’s and Movement Disorders Institute at Weill Cornell Medical Center in New York City. She read for her BA in Biochemistry and completed her graduate thesis at the University of Oxford in the UK. She then...

  • Dr. Art Kramer

    Dr. Kramer is Professor of Psychology and Director of the Center for Cognitive & Brain Health at Northeastern University. His research focuses on the understanding and enhancement of cognitive and neural plasticity across the lifespan. He has conducted a series of randomized clinical trials exploring the effects of aerobic fitness training and cognitive training...

  • Dr. Eric Parker

    Eric Parker has over 29 years of drug discovery and early development experience at BMS, Schering-Plough, Merck and, most recently, as a consultant for several biotechnology companies and venture firms. During his career, Eric has led programs in the areas of neurodegenerative disease, psychiatric disease, metabolic disease and supportive cancer care. He was a...

  • Dr. Joel Raskin

    Dr. Joel Raskin was a community and academic psychiatrist, consultant to public and private industry, before joining the pharmaceutical industry in 1999. He completed his medical training in 1981 and his psychiatric residency in 1986 at the University of Toronto, where he maintains an adjunct staff position in the Department of Psychiatry. He was...

  • Dr. David Simon (Chair)

    Dr. David K. Simon is the Director of the Parkinson’s Disease and Movement Disorders Center at the Beth Israel Deaconess Medical Center, a National Parkinson’s Disease Center of Excellence. He is also a Professor of Neurology at Harvard Medical School. Dr. Simon completed his undergraduate degree at Johns Hopkins followed by his MD and...

  • Dr. Malú Tansey

    Malú Gámez Tansey, Ph.D. is the Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, as well as the Norman and Susan Fixel Chair in Neuroscience and Neurology, Investigator at the Evelyn F. and William L McKnight Brain Institute. Prior to joining the team at University of Florida,...

  • Dr. Pierre Tariot

    Dr. Tariot is a Phi Beta Kappa graduate of Amherst College who attended the University of Rochester School of Medicine. He completed residencies in Internal Medicine and Psychiatry at the University of Wisconsin in Madison, Wisconsin, and is Board Certified in both specialties, with added qualifications in geriatrics. He served as a Fellow at...